SCHEMBL16355266

SCHEMBL16355266

c1ccc(-c2ccc(N(c3ccc(-c4ccc(-c5c6ccccc6c(-c6cccc7ccccc67)c6ccccc56)cc4)cc3)c3ccc(-c4cccnc4)cc3)cc2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 2/20 0.41
DHODH Q02127 2/20 0.39
NPC1 O15118 2/20 0.38
TP53 P04637 2/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP11B1 P15538 2/20 0.37
HTR2C P28335 1/20 0.36
TGFBR1 P36897 1/20 0.36
DCTPP1 Q9H773 2/20 0.36
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15158447 0.90 ALDH1A1 (0.47) CYP2A6SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL15158443 0.89 ALDH1A1 (0.46) CYP2A6SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL14463294 0.89 ALDH1A1 (0.46) CYP2A6SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL15158412 0.89 KDM4E (0.42) SMN1; SMN2KDM4EALDH1A1MAPTHPGD
SCHEMBL15158448 0.89 ALDH1A1 (0.46) CYP2A6SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL15158403 0.88 MAPK1 (0.43) SMN1; SMN2KDM4EALDH1A1MAPTHPGD
SCHEMBL16355273 0.86 DHODH (0.40) SMN1; SMN2KDM4EALDH1A1MAPTHPGD
SCHEMBL15237198 0.86 MAPT (0.40) SMN1; SMN2KDM4EALDH1A1MAPTHPGD
SCHEMBL17320751 0.86 CYP2A6 (0.49) CYP2A6SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL15237199 0.86 KDM4E (0.44) SMN1; SMN2KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9825244-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-21 US disclosed
US-9825244-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-21 US disclosed
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2016-10-20 US disclosed
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2016-10-20 US disclosed
US-9385336-B2 Organic light-emitting device using a mixture of electron transporting compounds SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-05 US disclosed
US-9385336-B2 Organic light-emitting device using a mixture of electron transporting compounds SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-05 US disclosed
US-20140374713-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-25 US disclosed
US-20140374713-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE ELMO1, ESR2, ELP1 CYP2A6 3420/4885SMN1; SMN2 1568/4885KDM4E 3314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.